Massaro, M.; Franceschini, D.; Spoto, R.; Dominici, L.; Franzese, C.; Baldaccini, D.; Marini, B.; di Cristina, L.; Marzo, M.A.; lo Faro, L.;
et al. Locally Advanced Non-Small Cell Lung Cancer: Clinical Outcome, Toxicity and Predictive Factors in Patients Treated with Hypofractionated Sequential or Exclusive Radiotherapy. Curr. Oncol. 2022, 29, 4893-4901.
https://doi.org/10.3390/curroncol29070388
AMA Style
Massaro M, Franceschini D, Spoto R, Dominici L, Franzese C, Baldaccini D, Marini B, di Cristina L, Marzo MA, lo Faro L,
et al. Locally Advanced Non-Small Cell Lung Cancer: Clinical Outcome, Toxicity and Predictive Factors in Patients Treated with Hypofractionated Sequential or Exclusive Radiotherapy. Current Oncology. 2022; 29(7):4893-4901.
https://doi.org/10.3390/curroncol29070388
Chicago/Turabian Style
Massaro, Maria, Davide Franceschini, Ruggero Spoto, Luca Dominici, Ciro Franzese, Davide Baldaccini, Beatrice Marini, Luciana di Cristina, Marco A. Marzo, Lorenzo lo Faro,
and et al. 2022. "Locally Advanced Non-Small Cell Lung Cancer: Clinical Outcome, Toxicity and Predictive Factors in Patients Treated with Hypofractionated Sequential or Exclusive Radiotherapy" Current Oncology 29, no. 7: 4893-4901.
https://doi.org/10.3390/curroncol29070388
APA Style
Massaro, M., Franceschini, D., Spoto, R., Dominici, L., Franzese, C., Baldaccini, D., Marini, B., di Cristina, L., Marzo, M. A., lo Faro, L., Paganini, L., Reggiori, G., Galdieri, C., Testori, A., & Scorsetti, M.
(2022). Locally Advanced Non-Small Cell Lung Cancer: Clinical Outcome, Toxicity and Predictive Factors in Patients Treated with Hypofractionated Sequential or Exclusive Radiotherapy. Current Oncology, 29(7), 4893-4901.
https://doi.org/10.3390/curroncol29070388
